leer
leer
leer
DeutschEnglishImprint
navifuellAbout usleerTechnology PlatformleerProduct PipelineleerHow to PartnerleerInvestor RelationsleerNewsleerContactleer
linie
leer
bildmotiv1
Motivpunkte
leer
leer

Novaliq is an independent private equity financed company. In five funding rounds the company successfully aquired a total capital sum of 27.1 Mio. Euros. The principal shareholder of the company is dievini Hopp BioTech Holding GmbH & Co. KG.

With its solid clinical and ready to market product portfolio, Novaliq provides a unique investment opportunity.

For further information on investment opportunities please contact us by Email: info[at]novaliq.de

 
leer
leer © 2016 Novaliq GmbH Germany. All rights reserved.